doi: 10.1093/jac/dkz277 388 SpellbergB
However, the literature does not yet provide a fully resolved primary molecular target, a unified causal mechanism, or sufficient controlled human evidence to support conclusions about therapeutic use
People with liver or kidney disease, G6PD deficiency, iron overload, or known allergies to any components should skip IV antioxidant therapy
Regulation of PI3K signaling in cancer metabolism and PI3K-targeting therapy
99.9% purity means the peptide makes up nearly all of the measured content, based on laboratory analysis methods used in peptide production
Researchers consulting this stream should attend to the framing carefully the carcinogenesis-suppression findings are mechanistic and preclinical, not therapeutic claims